UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 223,538 shares of the company's stock, valued at approximately $2,651,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.08% of Core Scientific at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise acquired a new stake in Core Scientific during the 2nd quarter worth about $28,000. Sunbelt Securities Inc. purchased a new position in Core Scientific in the 2nd quarter worth approximately $33,000. Divisadero Street Capital Management LP acquired a new position in Core Scientific in the second quarter valued at approximately $93,000. Rise Advisors LLC raised its position in Core Scientific by 14.3% in the third quarter. Rise Advisors LLC now owns 8,000 shares of the company's stock valued at $95,000 after purchasing an additional 1,000 shares during the period. Finally, Xponance Inc. purchased a new stake in Core Scientific in the second quarter valued at approximately $104,000.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on CORZ. Canaccord Genuity Group initiated coverage on shares of Core Scientific in a research note on Monday, September 23rd. They issued a "buy" rating and a $16.00 price objective for the company. Canaccord Genuity Group reiterated a "buy" rating and set a $17.00 target price on shares of Core Scientific in a research report on Thursday, November 7th. Roth Capital upgraded Core Scientific to a "strong-buy" rating in a research report on Thursday, November 14th. BTIG Research increased their target price on Core Scientific from $15.00 to $19.00 and gave the company a "buy" rating in a research note on Friday, November 15th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and issued a $20.00 target price on shares of Core Scientific in a research note on Thursday, October 3rd. Thirteen equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Core Scientific presently has a consensus rating of "Buy" and an average target price of $18.38.
Check Out Our Latest Analysis on Core Scientific
Insider Transactions at Core Scientific
In other Core Scientific news, Director Yadin Rozov sold 105,000 shares of the business's stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $18.11, for a total transaction of $1,901,550.00. Following the sale, the director now owns 345,239 shares of the company's stock, valued at approximately $6,252,278.29. The trade was a 23.32 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Todd M. Duchene sold 25,000 shares of the business's stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $17.10, for a total transaction of $427,500.00. Following the sale, the insider now directly owns 1,661,474 shares in the company, valued at approximately $28,411,205.40. The trade was a 1.48 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 32.00% of the company's stock.
Core Scientific Price Performance
CORZ stock traded up $0.01 during trading hours on Friday, reaching $15.55. 6,360,366 shares of the stock were exchanged, compared to its average volume of 9,054,852. The firm's 50-day moving average is $15.08 and its 200-day moving average is $11.71. The company has a market cap of $4.34 billion and a price-to-earnings ratio of -2.87. Core Scientific, Inc. has a 12 month low of $2.61 and a 12 month high of $18.63.
Core Scientific Company Profile
(
Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Featured Stories
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.